PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis

NCT ID: NCT04280601 Phase: NA Status: COMPLETED Enrollment: 102 Completion: 2023-03-01

Conditions

ANCA-associated Vasculitis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis With Polyangiitis

Interventions

vitamin D

Summary

This prospective study will assess if 12 months of vitamin D3 (cholecalciferol) supplementation, in patients with AAV (GPA, MPA, and EGPA) who have deficient or insufficient 25(OH)D3 status at enrollment, correlates with improved disease activity and/or lower frequency of relapse (compared to historical data and a previously conducted cross sectional study (part I) that assessed vitamin D status in a cohort of similar patients).

Primary Outcome

Disease activity and disease relapse (using BVAS)

Source

ClinicalTrials.gov